Evidence map›Paper›PMID 38956194›Full record

ArticleScientific reports2024

Autophagy and ubiquitin-dependent proteolysis processes in left ventricular mass loss in pulmonary arterial hypertension.

Mateusz K Hołda, Urszula Raźny, Maria Sordyl, Joanna Góralska, Maria Kapusta, Krystyna Słowińska-Solnica, Dorota Wojtysiak, Grzegorz Lis, Bogdan Solnica, Grzegorz Kopeć and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mateusz K HołdaHEART - Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Kopernika 12, 31-034, Kraków, Poland. mkh@onet.eu.
Urszula RaźnyDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland.
Maria SordylDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland.
Joanna GóralskaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland.
Maria KapustaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland.
Krystyna Słowińska-SolnicaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland.
Dorota WojtysiakDepartment of Animal Genetics, Breeding and Ethology, University of Agriculture in Cracow, Kraków, Poland.
Grzegorz LisDepartment of Histology, Jagiellonian University Medical College, Kraków, Poland.
Bogdan SolnicaDepartment of Clinical Biochemistry, Jagiellonian University Medical College, Kraków, Poland.
Grzegorz KopećDepartment of Cardiac and Vascular Diseases, Jagiellonian University Medical College, Kraków, Poland.
Jakub HołdaHEART - Heart Embryology and Anatomy Research Team, Department of Anatomy, Jagiellonian University Medical College, Kopernika 12, 31-034, Kraków, Poland.

Funding

National Science Centre, Poland 2016/23/N/NZ5/00597
6 · The paper itself

Abstract

The goal of this study was to evaluate the intensity of autophagy and ubiquitin-dependent proteolysis processes occurring in myocardium of left ventricle (LV) in subsequent stages of pulmonary arterial hypertension (PAH) to determine mechanisms responsible for LV mass loss in a monocrotaline-induced PAH rat model. LV myocardium samples collected from 32 Wistar rats were analyzed in an early PAH group (n = 8), controls time-paired (n = 8), an end-stage PAH group (n = 8), and their controls (n = 8). Samples were subjected to histological analyses with immunofluorescence staining, autophagy assessment by western blotting, and evaluation of ubiquitin-dependent proteolysis in the LV by immunoprecipitation of ubiquitinated proteins. Echocardiographic, hemodynamic, and heart morphometric parameters were assessed regularly throughout the experiment. Considerable morphological and hemodynamic remodeling of the LV was observed over the course of PAH. The end-stage PAH was associated with significantly impaired LV systolic function and a decrease in LV mass. The LC3B-II expression in the LV was significantly higher in the end-stage PAH group compared to the early PAH group (p = 0.040). The measured LC3B-II/LC3B-I ratios in the end-stage PAH group were significantly elevated compared to the controls (p = 0.039). Immunofluorescence staining showed a significant increase in the abundance of LC3 puncta in the end-stage PAH group compared to the matched controls. There were no statistically significant differences in the levels of expression of all ubiquitinated proteins when comparing both PAH groups and matched controls. Autophagy may be considered as the mechanism behind the LV mass loss at the end stage of PAH.

Indexed as

AutophagyHeart VentriclesProteolysisPulmonary Arterial HypertensionRats, WistarUbiquitinAnimalsDisease Models, AnimalEchocardiographyHypertension, PulmonaryMaleMyocardiumRatsVentricular RemodelingUbiquitinCardiac autophagyCardiac remodelingLeft ventricle atrophyMonocrotaline-induced PAHPulmonary hypertensionUbiquitin–proteasome system

Identifiers

PMID38956194
PMCPMC11220073

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.